Company Email Format Management

Nextera AS

Biotechnology Research No 16 employees

Employees: 16
Contacts: 1
Emails: 1

www.nextera.no LinkedIn Crunchbase

Nextera AS Overview

Headquarters: No
Phone Number: Available in AeroLeads
Website: www.nextera.no
Industry: Biotechnology Research
Employees: 16
Founded: 2009
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Nextera AS

Nextera is a drug and target discovery company offering a unique and novel approach for improved therapeutic intervention in the major disease areas autoimmunity, chronic inflammatory disorders and cancer. Our approach is to modulate the disease at the core of the escalating immune cascade translating to disease-specific treatment without compromising systemic immunity. Our strategy is to discover new targets and develop cognate drugs together with partners. We want to address complex diseases and jointly develop therapies in major indications that today seem difficult to treat. It all starts and ends with the patient – focused onto to diseased tissue and the underlying immune repertoires, Nextera brings the unique ability to decipher clinical material with the outlook of subsequent intervention.

Nextera AS Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

Nextera AS Org Chart

Sample employees and titles

Name	Title	Location	Contact
Sebastian Berge-Seidl	Group Lead Molecular Biology - Ph.d. in Molecular Biology	Oslo, Norway	Email
Bent Jakobsen	Founder & Chief Executive Officer at Accession Therapeutics Limited		View
Hans Ivar Robinson	CEO and Founder of Birk Venture, Executive Chairman and Co-founder of Nextera, Co-founder and Non-executive Director of Zelluna, Non-executive		View